Use of modeling techniques to aid in antibiotic selection

被引：13
作者：
Alexander A. Firsov
Stephen H. Zinner
机构：
[1] Centre for Science & Technology LekBioTech,Department of Pharmacokinetics
[2] Harvard Medical School,Mount Auburn Hospital
来源：
Current Infectious Disease Reports | 2001年 / 3卷 / 1期
关键词：
Levofloxacin; Moxifloxacin; Antimicrob Agent; Antimicrobial Effect; Gatifloxacin;
D O I：
10.1007/s11908-001-0057-9
中图分类号：
学科分类号：
摘要：
Over the past decade, the use of modeling techniques in the development of novel antibiotics has been primarily associated with in vitro dynamic models. These models allow comparisons among different antibiotics by simulating human pharmacokinetics. Although dynamic models have been used extensively, their full potential has not been achieved because of inadequate experimental design and/or suboptimal quantitation of bacterial killing/regrowth curves inherent in many studies. These issues are discussed in this review, which is based on recent pharmacodynamic findings with novel fluoroquinolones.
引用
收藏
页码：35 / 43
页数：8
相关论文
共 105 条
[1]  
Blaser J(1987)In vitro models for the study of antibiotic activities Progr Drug Res 31 349-381
[2]  
Zinner SH(1989)Pharmacokinetic approaches to rational antibiotic therapy [in Russian] Adv Sci Eng 17 1-228
[3]  
Firsov AA(1985)Historical review of in-vitro models J Antimicrob Chemother 15 99-102
[4]  
Nazarov AD(1981)In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance J Infect Dis 144 380-385
[5]  
Chernykh VM(1997)Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: action of ciprofloxacin against Escherichia coli in an in vitro dynamic model Antimicrob Agents Chemother 41 1281-1287
[6]  
Grasso S(1988)Evaluation of ceftriaxone and other antibiotics against Escherichia coli, Pseudomonas aeruginosa, and Streptococcus pneumoniae under in vitro conditions simulating those of serious infections Antimicrob Agents Chemother 32 552-560
[7]  
Greenwood D(1985)Study on the antibactericidal activity of ceftazidime in an in vitro pharmacokinetic model Drugs Exp Clin Res 11 49-54
[8]  
Firsov AA(1981)Antibacterial activity of cefuroxime in an in vitro pharmacokinetic model Drugs Exp Clin Res 7 459-464
[9]  
Vostrov SN(1994)Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model Antimicrob Agents Chemother 38 2480-2482
[10]  
Shevchenko AA(1981)Bactericidal activity of ceftazidime against Pseudomonas aeruginosa under conditions simulating serum pharmacokinetics J Antimicrob Chemother 8 135-140
12345678910